Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sigrun Greil-Ressler"'
Autor:
Michael, Gnant, Florian, Fitzal, Gabriel, Rinnerthaler, Guenther G, Steger, Sigrun, Greil-Ressler, Marija, Balic, Dietmar, Heck, Raimund, Jakesz, Josef, Thaler, Daniel, Egle, Diether, Manfreda, Vesna, Bjelic-Radisic, Ursula, Wieder, Christian F, Singer, Elisabeth, Melbinger-Zeinitzer, Ferdinand, Haslbauer, Paul, Sevelda, Harald, Trapl, Viktor, Wette, Kerstin, Wimmer, Simon P, Gampenrieder, Rupert, Bartsch, Stephanie, Kacerovsky-Strobl, Christoph, Suppan, Christine, Brunner, Christine, Deutschmann, Lidija, Soelkner, Christian, Fesl, Richard, Greil, B, Tausch
Publikováno v:
New England Journal of Medicine. 385:395-405
For postmenopausal women with hormone-receptor-positive breast cancer, the most effective duration for adjuvant therapy with an aromatase inhibitor remains unclear.In this prospective, phase 3 trial, we randomly assigned postmenopausal women with hor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db595c6fbe9f60a7a84e61bf9ccfb73
https://doi.org/10.1056/nejmoa2104162
https://doi.org/10.1056/nejmoa2104162
Autor:
Thomas Melchardt, Stefanie Jilg, Philipp J Jost, Florian Huemer, Bettina Jansko, Theresa Magnes, Eckhard Klieser, Richard Greil, Christof Rass, Lisa Pleyer, Alexander Egle, Sigrun Greil-Ressler, Adam Wahida, Katja Steiger
Publikováno v:
Kompass Onkologie. 7:107-110
Die akute myeloische Leukämie (AML) ist eine Erkrankung, die vor allem ältere Menschen betrifft, und die Überlebenschancen nach Versagen von hypomethylierenden Wirkstoffen (hypomethylating agents, HMAs) sind nach wie vor gering. Der BCL-2-Inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d246132268603f2cc73766c247745ff
https://doi.org/10.1159/000508214
https://doi.org/10.1159/000508214
Autor:
Teresa Magnes, Lukas Weiss, Richard Greil, Peter P. Sordillo, Gordon T. Bolger, Brigitta Vcelar, Sigrun Greil-Ressler, Bianca Radl, Charlotte Schönlieb
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose This study was conducted to investigate the safety and tolerability of increasing doses of liposomal curcumin in patients with metastatic cancer. Investigations of anti-tumor activity and of the pharmacokinetics of curcumin were secondary obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163a0ae960923bd7e78a1f60dfd6925a
https://doi.org/10.1007/s00280-018-3654-0
https://doi.org/10.1007/s00280-018-3654-0
Autor:
Bettina Jansko, Lisa Pleyer, Daniel Neureiter, Christoph Rass, Carmen Feierabend, Lukas Rettenbacher, Richard Greil, Olga Stiefel, Patrick Morre, Sigrun Greil-Ressler
Publikováno v:
Oncotarget
Primary resistant Hodgkin lymphoma is an aggressive disease with few treatment options and short survival. Neoplastic cells of classical Hodgkin lymphoma are heavily dependent on microenvironmental stimuli, regularly express PD-L1, and a relevant pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d89ea799bf4f7e1e2d8bd52a132e6a
http://europepmc.org/articles/PMC5945535
http://europepmc.org/articles/PMC5945535
Autor:
Stefanie Jilg, Teresa Magnes, Richard Greil, Alexander Egle, Thomas Melchardt, Florian Huemer, Adam Wahida, Philipp J. Jost, Lisa Pleyer, Sigrun Greil-Ressler, Eckhard Klieser, Katja Steiger, Bettina Jansko, Christof Rass
Publikováno v:
European Journal of Haematology
Acute myeloid leukemia (AML) is a disease of the elderly population and survival remains poor after failure of hypomethylating agents (HMA). The BCL-2 inhibitor venetoclax demonstrated activity as monotherapy and in combination with chemotherapy or H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fcb9a62c09ebf54331c9520e46b1ba8
https://mediatum.ub.tum.de/1538487
https://mediatum.ub.tum.de/1538487
Autor:
Brigitta Vcelar, Teresa Magnes, Charlotte Schönlieb, Gordon T. Bolger, Lukas Weiss, Peter P. Sordillo, Muhammed Majeed, Albert Licollari, Bianca Radl, Sigrun Greil-Ressler, Richard Greil, Amin Tan
Publikováno v:
Cancer chemotherapy and pharmacology. 83(2)
Investigation of the impact of co-medication on the plasma levels of curcumin and tetrahydrocurcumin (THC) in cancer patients and a comparison of the pharmacokinetics of curcumin and plasma levels of THC between cancer patients and healthy individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56109ac046c307dc030d793d3aed3352
https://pubmed.ncbi.nlm.nih.gov/30430227
https://pubmed.ncbi.nlm.nih.gov/30430227